NCT01537211

Brief Summary

In older adults, poor circulation in the lower extremities leads to serious health complications including limb loss. In addition, individuals with dysvascular disease also suffer from other co-morbidities like diabetes, coronary and cerebrovascular disease. An individual with a transfemoral (TF) amputation is usually fitted with a prosthetic limb to assist with function, including a prosthetic knee and a prosthetic foot. Currently, dysvascular amputees are given a prosthetic knee based on the basic expectation that they will be functionally stable. This consideration does not address higher levels of function like walking at multiple speeds and over uneven ground. Also, dysvascular amputees are not able to counteract their co-morbidities with a more active lifestyle. Walking is less energy efficient; their traditional prostheses may cause early onset of fatigue and induce a fear of falling. Newer microprocessor knees enable patients with transfemoral amputations to walk on different surfaces and at multiple cadences through better control in swing and stance phases of gait. The impact of the functional differences in the prostheses is not clear and requires additional investigation to clarify the choice of the most appropriate functional prosthesis. The purpose of this study is to compare the functional outcomes with the traditional mechanical knee versus the microprocessor knee (C-leg) in transfemoral amputees.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2011

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

February 7, 2012

Completed
16 days until next milestone

First Posted

Study publicly available on registry

February 23, 2012

Completed
7.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2019

Completed
5 months until next milestone

Results Posted

Study results publicly available

September 6, 2019

Completed
Last Updated

September 6, 2019

Status Verified

August 1, 2019

Enrollment Period

7.7 years

First QC Date

February 7, 2012

Results QC Date

May 17, 2019

Last Update Submit

August 15, 2019

Conditions

Keywords

Dysvascularamputationabove kneeambulation

Outcome Measures

Primary Outcomes (1)

  • Change in Community Physical Activity as Measured by GPS

    The difference in social mobility (as seen by GPS) between the 2 devices will be measured.

    baseline, 1 month with mechanical knee, 1 month with microprocessor knee

Secondary Outcomes (9)

  • Change in 6 Minute Walk Test From Baseline

    After 3 month acclimation period to device

  • Change in 10 Meter Walk Test Gait Speed From Baseline

    After 3 month acclimation period to device

  • Change in Amputee Mobility Predictor Score From Baseline

    After 3 month acclimation period to device

  • Change in Berg Balance Score From Baseline

    After 3 month acclimation period to device

  • Change in Timed Up and Go Test Time From Baseline

    After 3 month acclimation period to device

  • +4 more secondary outcomes

Study Arms (2)

Microprocessor knee then Mechanical knee

EXPERIMENTAL
Device: C leg compared to subject's mechanical leg (Otto Bock)

Mechanical Knee then Microprocessor knee

EXPERIMENTAL
Device: C leg compared to subject's mechanical leg (Otto Bock)

Interventions

comparison of different prosthetic knees

Also known as: Otto Bock
Mechanical Knee then Microprocessor knee

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Males or females with dysvascular transfemoral amputations
  • months or more post prosthetic fitting
  • Homebound or limited community ambulators post amputation
  • Ability to walk \> 50m in a 2 min walk test

You may not qualify if:

  • Traumatic, cancer or genetic amputation
  • Co-morbidity that completely prevents physical activity
  • Significant skin lesions/ulcers on stump that prevent fitting of prosthesis
  • Cognitive deficits or visual impairments that would impair their ability to give informed consent or to follow simple instructions during experiment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Rehabilitation Institute of Chicago, 345 E Superior St

Chicago, Illinois, 60611, United States

Location

Related Publications (2)

  • Theeven P, Hemmen B, Rings F, Meys G, Brink P, Smeets R, Seelen H. Functional added value of microprocessor-controlled knee joints in daily life performance of Medicare Functional Classification Level-2 amputees. J Rehabil Med. 2011 Oct;43(10):906-15. doi: 10.2340/16501977-0861.

    PMID: 21947182BACKGROUND
  • Jayaraman C, Mummidisetty CK, Albert MV, Lipschutz R, Hoppe-Ludwig S, Mathur G, Jayaraman A. Using a microprocessor knee (C-Leg) with appropriate foot transitioned individuals with dysvascular transfemoral amputations to higher performance levels: a longitudinal randomized clinical trial. J Neuroeng Rehabil. 2021 May 25;18(1):88. doi: 10.1186/s12984-021-00879-3.

Results Point of Contact

Title
Arun Jayaraman, PT, PhD; Director of Max Nader Lab for Rehabilitation Technologies and Outcomes
Organization
Rehabilitation Institute of Chicago

Study Officials

  • Arun Jayaraman, PT PhD

    Shirley Ryan AbilityLab

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, Rehab Technolgoies and Outcomes Lab

Study Record Dates

First Submitted

February 7, 2012

First Posted

February 23, 2012

Study Start

August 1, 2011

Primary Completion

April 1, 2019

Study Completion

April 1, 2019

Last Updated

September 6, 2019

Results First Posted

September 6, 2019

Record last verified: 2019-08

Locations